Israel - English - Ministry of Health

ferring pharmaceuticals ltd - somatropin - powder and solvent for solution for injection - somatropin 10 mg - somatropin - somatropin - children :short stature due to inadequate or failed secretion of pituitary growth hormone or turner's syndrome. short stature in children with renal insufficiency.

Ireland - English - HPRA (Health Products Regulatory Authority)

helsinn birex pharmaceuticals limited - macrogol 3350 - powder for oral solution - 5.9 gram(s) - osmotically acting laxatives; macrogol, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

stirling anglian pharmaceuticals ltd - macrogol 3350; sodium chloride; potassium chloride; sodium hydrogen carbonate - powder for oral solution - 6.9 gram(s) - osmotically acting laxatives; macrogol, combinations - osmotically acting laxatives - for the treatment of chronic constipation in adults, adolescents and the elderly. for resolving faecal impaction in adults, adolescents and the elderly. faecal impaction is defined as refractory constipation with faecal loading in the rectum and/or colon confirmed by physical or radiological examination of the abdomen and rectum.

Ireland - English - HPRA (Health Products Regulatory Authority)

stirling anglian pharmaceuticals ltd - macrogol 3350; sodium chloride; potassium chloride; sodium hydrogen carbonate - powder for oral solution - 6.9 gram(s) - osmotically acting laxatives; macrogol, combinations - osmotically acting laxatives - for the treatment of chronic constipation in children aged 2 to 11 years. for the treatment of faecal impaction in children aged 5 years or above. faecal impaction is defined as refractory constipation with faecal loading in the rectum and/or colon.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 665 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; povidone; sodium starch glycollate type a; microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; macrogol 6000; maize starch; pregelatinised maize starch; hypromellose - effective for the relief of persistent pain associated with osteoarthritis and muscle aches and pains such as backache. pharmacy choice osteo relief paracetamol 665 mg also provides effective, temporary relief of pain and discomfort associated with headache, tension headache, period pain, toothache and pain after dental procedures, and cold and flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; macrogol 3350, quantity: 13125 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6562.5 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.4 mg; sodium bicarbonate, quantity: 89.3 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6.563 g - granules - excipient ingredients: acesulfame potassium; flavour - for use in adults and children over 2 years for effective relief from constipation, treatment of chronic constipation and resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum. for use in children aged 2 years and older for prevention of recurrence of faecal impaction.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg; macrogol 3350, quantity: 13.125 g; potassium chloride, quantity: 46.6 mg - granules - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

Australia - English - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - pseudoephedrine hydrochloride, quantity: 30 mg; chlorphenamine maleate, quantity: 2 mg; paracetamol, quantity: 500.4 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; pregelatinised maize starch; povidone; purified water; erythrosine aluminium lake; stearic acid - temporary relief of the symptoms of sinus headache, pain and nasal congestion (including fever) and hay fever.